comparemela.com
Home
Live Updates
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of ... : comparemela.com
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of ...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional
Related Keywords
China ,
Illinois ,
United States ,
Canada ,
University Of Illinois ,
America ,
Rick Rodgers ,
Paul Hoelscher ,
Dave Happel ,
Maria Yonkoski ,
Jinzi Wu ,
Asia Pacific ,
George Kemble ,
Tim Walbert ,
Sagimet Biosciences ,
Mirum Pharmaceuticals ,
Amgen ,
Raptor Pharmaceutical Corp ,
Nasdaq ,
Merck Co ,
Mallinckrodt Pharmaceuticals ,
Reneo Pharmaceuticals Inc ,
Neopharm Inc ,
Gd Searle Company ,
University Of Illinois At Urbana Champaign ,
Pharma Inc ,
Exchange Commission ,
Aurinia Pharmaceuticals ,
Takeda America Holdings Inc ,
Sucampo Pharmaceuticals Inc ,
Leukemia Lymphoma Society ,
Sagimet Biosciences Inc ,
Horizon Therapeutics ,
Takeda America Holdings ,
Latin America ,
Century Therapeutics ,
Reneo Pharmaceuticals ,
Illinois Region ,
Lymphoma Society ,
Greater China ,
Private Securities Litigation Reform Act ,
Region ,
comparemela.com © 2020. All Rights Reserved.